Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

Press Releases

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Proterra Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PTRA

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Proterra Inc. (NASDAQ: PTRA) between August 2, 2022 and March 15, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DHR

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSE: DHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

EB5 Capital’s Riverfront at the Navy Yard (JF8) Project Receives First I-829 Approval

WASHINGTON, July 24, 2023 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce that it has received notice from the United States Citizenship and Immigration Services (USCIS) regarding the first I-829 petition approval associated with an investor in the firm’s Riverfront at the Navy Yard (JF8) project. The I-829 approval marks a significant achievement for […]

APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) resulting from allegations that Apellis may have issued materially misleading business information to the investing public. SO WHAT: If […]

Bybit and Oracle Red Bull Racing Introduce ‘Velocity Series,’ a Groundbreaking Digital Art Collaboration

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 24 July 2023 – Bybit, the world’s third most visited cryptocurrency exchange, is delighted to introduce the Velocity Series, an unprecedented collaboration between Bybit, Oracle Red Bull Racing, and renowned digital artists. This initiative will merge art and racing by creating unique digital collectibles inspired by race […]

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™) ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia […]

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

London, UK, July 24, 2023 (GLOBE NEWSWIRE) — OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, today announced a new team of experts will lead its HEOR & Market Access Scientific Office. This expert team will be led by Dr. Elisabeth Fenwick as Chief Scientific Officer with support from Professor Ben van […]

Bybit Raises the Bar: VIP Program Upgrades Set to Redefine the Trading Experience

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 21 July 2023 – Bybit, the world’s third most visited crypto exchange, has unveiled its newly revamped VIP program. With a focus on enhancing user satisfaction and optimizing trading opportunities, the revamped VIP program introduces a range of new features and benefits. Notable changes include revised fee […]